Patent · US Active

Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide

US10479794B2 · kind B2 · utility

2Cited by

6References

73Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Christoph Hoenke · Ingelheim am Rhein, DE
Barbara Bertani · Castiglione delle Stiviere, IT
Marco Ferrara · San Donato Milanese, IT
Giacomo Fossati · Lissone, IT
Sara Frattini · Castelleone, IT
Riccardo Giovannini · Verona, IT
Scott Hobson · Mittelbiberach, DE

Key dates

Filing date	Jan 9, 2018
Grant date	Nov 19, 2019
Priority date	—
Expiry date	Jan 9, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide of general formula (I) which are inhibitors of phosphodiesterase 2, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.